Novo Integrated Sciences Total Non-Operating Income/Expense 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novo Integrated Sciences total non-operating income/expense from 2012 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Novo Integrated Sciences Total Non-Operating Income/Expense 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novo Integrated Sciences total non-operating income/expense from 2012 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$21.4B
Quest Diagnostics (DGX)	$17.3B
DaVita (DVA)	$13.8B
Encompass Health (EHC)	$9.2B
Chemed (CHE)	$8.7B
Elanco Animal Health (ELAN)	$7.1B
Option Care Health (OPCH)	$5.3B
RadNet (RDNT)	$4.9B
Amedisys (AMED)	$3.2B
Astrana Health (ASTH)	$2.7B
LifeStance Health (LFST)	$2.6B
Addus HomeCare (ADUS)	$2.4B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$1B
Aveanna Healthcare Holdings (AVAH)	$1B
Atai Life Sciences (ATAI)	$215M
Daxor (DXR)	$46M
ATI Physical Therapy (ATIP)	$26M
MEDIROM Healthcare Technologies (MRM)	$19M
Psychemedics (PMD)	$14M
Ontrak (OTRK)	$10M
IMAC Holdings (BACK)	$2M